Clinical safety and hypothalamic-pituitary-adrenal axis effects of the arginine vasopressin type 1B receptor antagonist ABT-436. (Q52148833)
Jump to navigation
Jump to search
scientific article published on 26 September 2015
Language | Label | Description | Also known as |
---|---|---|---|
English | Clinical safety and hypothalamic-pituitary-adrenal axis effects of the arginine vasopressin type 1B receptor antagonist ABT-436. |
scientific article published on 26 September 2015 |
Statements
Clinical safety and hypothalamic-pituitary-adrenal axis effects of the arginine vasopressin type 1B receptor antagonist ABT-436. (English)
1 reference
David A Katz
1 reference
Wei Liu
1 reference
Charles Locke
1 reference
Sandeep Dutta
1 reference
Katherine A Tracy
1 reference
26 September 2015
1 reference
233
1 reference
1
1 reference
71-81
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference